missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Dapagliflozin ((2S)-1,2-propanediol, hydrate), MedChemExpress
Descripción
Dapagliflozin ((2S)-1,2-propanediol, hydrate), a new type of drug used to treat diabetes mellitus (DM), is a competitive sodium/glucose cotransporter 2 (SGLT2) inhibitor, which results in excretion of glucose into the urine. Dapagliflozin ((2S)-1,2-propanediol, hydrate) induces HIF1 expression and attenuates renal IR injury.
Specifications
Specifications
| Nombre del producto químico o material | Dapagliflozin ((2S)-1,2-propanediol, hydrate) |
| CAS | 960404-48-2 |
| Color | Blanco |
| Notas de grado de pureza | Research |
| Fórmula molecular | C24H35ClO9 |
| Cantidad | 50 mg |
| Sinónimo | BMS-512148 (2S)-1,2-propanediol, hydrate |
| Información de solubilidad | DMSO : ≥ 100 mg/mL (198.82 mM) ∣H2O : 2.38 mg/mL (4.73 mM; Need ultrasonic) |
| SMILES | O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O.C[C@H](O)CO.O |
| Peso molecular (g/mol) | 502.98 |
| Show More |
Research purposes only
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?